Δημοσιεύσεις

2026

1. Nanoparticle-based drug carriers in transdermal and topical delivery: An in vivo review of anti-inflammatory efficacy. (2026) Biochemical Pharmacology, 244, art. no. 117567. DOI: 10.1016/j.bcp.2025.117567
2. Modeling oxidative stress on neuronal dendrites and dendritic spines. (2026) Neuroscience, 592, pp. 157 – 166. DOI: 10.1016/j.neuroscience.2025.11.037

2025

1. Real-world performance evaluation of a telemonitoring system for Parkinson’s disease symptom assessment. (2025) Journal of Clinical Neuroscience, 136, art. no. 111285. DOI: 10.1016/j.jocn.2025.111285
2. Decellularized scaffolds and heart valve treatment: present techniques, long-standing hurdles and the challenging future. (2025) Biomaterials Advances, 177, art. no. 214367. DOI: 10.1016/j.bioadv.2025.214367
3. Enhancing Ultrasound-Based Diagnosis of Unilateral Diaphragmatic Paralysis With a Visual Transformer-Based Model. (2025) IEEE Journal of Biomedical and Health Informatics, 29 (10), pp. 7349 – 7358. DOI: 10.1109/JBHI.2025.3580447
4. N-Doped Graphene for Biomedical Applications: A Comparative Biocompatibility Assessment of Green and Chemical Exfoliation. (2025) Chemical research in toxicology, 38 (9), pp. 1509 – 1523. DOI: 10.1021/acs.chemrestox.5c00167
5. Exploring the mid-term impact of telemonitoring in Parkinson’s disease: insights from adoption into clinical practice. (2025) Neurodegenerative Disease Management. DOI: 10.1080/17582024.2025.2562754
6. Economic evaluation of mHealth solutions in PD: where do we stand? (2025) Neurodegenerative Disease Management, 15 (1), pp. 5 – 8. DOI: 10.1080/17582024.2025.2467020
7. Revolutionizing Heart Valve Therapy: A Translational Framework for Combining Decellularized Scaffolds With Genetic Modification. (2025) Journal of Biomedical Materials Research – Part B Applied Biomaterials, 113 (11), art. no. e35686. DOI: 10.1002/jbm.b.35686
8. The role of the hypothalamus in the development of cancer cachexia. (2025) Physiology and Behavior, 295, art. no. 114909. DOI: 10.1016/j.physbeh.2025.114909
9. Accessibility to Primary Health Services and Quality of Life in Patients with Type 2 Diabetes Mellitus in Mountainous Greece. (2025) Sci, 7 (1), art. no. 9. DOI: 10.3390/sci7010009
10. The SGLT2 inhibitor empagliflozin exerts neuroprotective effect against hydrogen peroxide-induced toxicity on primary neurons. (2025) Metabolic Brain Disease, 40 (1), art. no. 15. DOI: 10.1007/s11011-024-01478-6
11. The treatment interventions and targets of cancer cachexia research during the past decade: a systematic review of the literature. (2025) Annals of Gastroenterology, 38 (1), pp. 85 – 92. DOI: 10.20524/aog.2024.0918

2024

1. Exploring the Cellular Interactions of Flavonoids with Similar Structures in Cells Overexpressing the 70 kDa Human Heat Shock Protein. (2024) Applied Biosciences, 3 (1), pp. 137 – 150. DOI: 10.3390/applbiosci3010009
2. Graphene oxide and oxidized carbon nanodiscs as biomedical scaffolds for the targeted delivery of quercetin to cancer cells. (2024) Nanoscale Advances, 6 (11), pp. 2860 – 2874. DOI: 10.1039/d3na00966a.
3. Carpal Tunnel Syndrome Automated Diagnosis: A Motor vs. Sensory Nerve Conduction-Based Approach. (2024) Bioengineering, 11 (2), art. no. 175. DOI: 10.3390/bioengineering11020175
4. Firing Alterations of Neurons in Alzheimer’s Disease: Are They Merely a Consequence of Pathogenesis or a Pivotal Component of Disease Progression? (2024) Cells, 13 (5), art. no. 434. DOI: 10.3390/cells13050434
5. A Strategic Synthesis of Orange Waste-Derived Porous Carbon via a Freeze-Drying Method: Morphological Characterization and Cytocompatibility Evaluation. (2024) Molecules, 29 (16), art. no. 3967. DOI: 10.3390/molecules29163967
6. Glioblastoma research on zebrafish xenograft models: a systematic review. (2024) Clinical and Translational Oncology, 26 (2), pp. 311 – 325. DOI: 10.1007/s12094-023-03258-7
7. Cell replacement therapy with stem cells in multiple sclerosis, a systematic review. (2024) Human Cell, 37 (1), pp. 9 – 53. DOI: 10.1007/s13577-023-01006-1
8. Enhancement of the biological activity of hydroxytyrosol through its oxidation by laccase from Trametes versicolor. (2024) Journal of Biotechnology, 385, pp. 30 – 41. DOI: 10.1016/j.jbiotec.2024.02.011
9. Longitudinal Muscle Biopsies Reveal Inter- and Intra-Subject Variability in Cancer Cachexia: Paving the Way for Biopsy-Guided Tailored Treatment. (2024) Cancers, 16 (5), art. no. 1075. DOI: 10.3390/cancers16051075

2023

1. Is graphene the rock upon which new era continuous glucose monitors could be built? (2023) Experimental Biology and Medicine, 248 (1), pp. 14 – 25. DOI: 10.1177/15353702221134105
2. Effect of Highly Hydrophilic Superparamagnetic Iron Oxide Nanoparticles on Macrophage Function and Survival. (2023) Journal of Functional Biomaterials, 14 (10), art. no. 514. DOI: 10.3390/jfb14100514
3. Clinical Evaluation in Parkinson’s Disease: Is the Golden Standard Shiny Enough? (2023) Sensors, 23 (8), art. no. 3807. DOI: 10.3390/s23083807
4. Does Green Exfoliation of Graphene Produce More Biocompatible Structures? (2023) Pharmaceutics, 15 (3), art. no. 993. DOI: 10.3390/pharmaceutics15030993
5. Hydroxytyrosol produced by engineered Escherichia coli strains activates Nrf2/HO-1 pathway: An in vitro and in vivo study. (2023) Experimental Biology and Medicine, 248 (18), pp. 1598 – 1612. DOI: 10.1177/15353702231187647
6. Cellular Localization of Orexin 1 Receptor in Human Hypothalamus and Morphological Analysis of Neurons Expressing the Receptor. (2023) Biomolecules, 13 (4), art. no. 592. DOI: 10.3390/biom13040592. 
7. Highly Hydrophilic Oleylamine-Modified Superparamagnetic Iron Oxide Nanoparticles for Biomedical Applications. (2023) ACS Applied Nano Materials, 6 (4), pp. 2770 – 2783. DOI: 10.1021/acsanm.2c04006
8. Synthesis, characterization, and biocompatibility studies of a new lanthanum-cerium synthetic aminoclay analogue. (2023) Applied Materials Today, 35, art. no. 102006. DOI: 10.1016/j.apmt.2023.102006
9. Oral Supplementation with Hydroxytyrosol Synthesized Using Genetically Modified Escherichia coli Strains and Essential Oils Mixture: A Pilot Study on the Safety and Biological Activity. (2023) Microorganisms, 11 (3), art. no. 770. DOI: 10.3390/microorganisms11030770
10. Oxidized-Multiwalled Carbon Nanotubes as Non-Toxic Nanocarriers for Hydroxytyrosol Delivery in Cells. (2023) Nanomaterials, 13 (4), art. no. 714. DOI: 10.3390/nano13040714

2022

1. Production of hydroxytyrosol rich extract from Olea europaea leaf with enhanced biological activity using immobilized enzyme reactors. (2022) Environmental Science and Pollution Research, 29 (20), pp. 29624 – 29637. DOI: 10.1007/s11356-021-17081-6
2. Binuclear VIV/V, MoVI and ZnII – hydroquinonate complexes: Synthesis, stability, oxidative activity and anticancer properties. (2022) Journal of Inorganic Biochemistry, 235, art. no. 111911. DOI: 10.1016/j.jinorgbio.2022.111911
3. New treatment approaches for Alzheimer’s disease: preclinical studies and clinical trials centered on antidiabetic drugs. (2022) Expert Opinion on Investigational Drugs, 31 (1), pp. 105 – 123. DOI: 10.1080/13543784.2022.2022122
4. Clinical features and diagnostic tools in idiopathic inflammatory myopathies. (2022) Critical Reviews in Clinical Laboratory Sciences, 59 (4), pp. 219 – 240. DOI: 10.1080/10408363.2021.2000584

2021

1. Vanadium(V) complexes with siderophore vitamin e-hydroxylamino-triazine ligands. (2021) Inorganics, 9 (10), art. no. 73. DOI: 10.3390/inorganics9100073
2. Trends of nanotechnology in type 2 diabetes mellitus treatment. (2021) Asian Journal of Pharmaceutical Sciences, 16 (1), pp. 62 – 76. DOI: 10.1016/j.ajps.2020.05.001

2020

1. Synthesis of vitamin E and aliphatic lipid vanadium(IV) and (V) complexes, and their cytotoxic properties. (2020) Journal of Inorganic Biochemistry, 208, art. no. 111074. DOI: 10.1016/j.jinorgbio.2020.111074